Search results for “Hypereosinophilic syndrome” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 216 patents, we discovered top 52 key players by total patent application. Deciphera Pharmaceuticals, Inc., Novartis AG, Glaxosmithkline Intellectual Property Development Ltd. are dominant in this area. They take 46.76% of the total patent filing.
Massachusetts, United States
Patent: 57
Basel-Stadt, Switzerland
Patent: 26
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 18
STARTUP
California, United States
Patent: 13
Quebec, Canada
Patent: 6
Osaka-fu, Japan
Patent: 6
Queensland, Australia
Patent: 5
Pennsylvania, United States
Patent: 5
Rheinland-Pfalz, Germany
Patent: 4
Japan
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 14 patents, we discovered top 2 start-ups by total patent application.
STARTUP
California, United States
Patent: 13
STARTUP
Areteia Therapeutics, Inc.
New Jersey, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 45 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Glaxosmithkline Intellectual Property Development Ltd., Deciphera Pharmaceuticals, Inc., Blueprint Medicines Corp. take 60.00% of patent filing during this period.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 18
Massachusetts, United States
Patent: 6
Massachusetts, United States
Patent: 3
STARTUP
California, United States
Patent: 2
Pennsylvania, United States
Patent: 2
Tennessee, United States
Patent: 2
Colorado, United States
Patent: 2
Aberdeen City, United Kingdom
Patent: 1
South Korea
Patent: 1
Pennsylvania, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 45 patents in last 5 years, we discover 9 new entrants. Glaxosmithkline Intellectual Property Development Ltd., Blueprint Medicines Corp., ReversPAH LLC are the most active new entrants in this area.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 18
Massachusetts, United States
Patent: 3
Colorado, United States
Patent: 2
Tennessee, United States
Patent: 2
Aberdeen City, United Kingdom
Patent: 1
Virginia, United States
Patent: 1
Pennsylvania, United States
Patent: 1
South Korea
Patent: 1
Jiangsu Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 23 patents, we discovered top 6 universities and scientific research institutions by total patent application. Université Libre de Bruxelles, Université Catholique de Louvain, Vanderbilt University are dominant in this area. They take 43.48% of the total patent filing.
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 4
Vlaams-Brabant, Belgium
Patent: 4
Tennessee, United States
Patent: 2
Taiwan Province, China
Patent: 2
Taiwan Province, China
Patent: 1
Chile
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: